Laboratorios Gebro Pharma SA - Company Review
Laboratorios Gebro Pharma SA - Company ReviewSummary
Laboratorios Gebro Pharma SA (Laboratorios Gebro), a subsidiary of Gebro Pharma GmbH is a pharmaceutical company that offers pain and rheumatology services. The company develops and commercializes drugs for pain and rheumatology. It provides products in the areas of oncology, rheumatology, urology, pain, respiratory and other specialty drugs. Laboratorios Gebro’s rheumatology products are served for the treatment of vitamin D deficiency, active rheumatoid arthritis. The company’s pain products are used for the treatment of indications of pain related to severe cancer, moderate to severe pain and intense pain. Its other activities include co-promotion, co-marketing and exclusive distribution agreements. The company operates through other companies in the pharmaceutical and biotechnology sectors. Laboratorios Gebro is headquartered in Barcelona, Spain.
This comprehensive company report of Laboratorios Gebro Pharma SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.